The tech-laden Nasdaq Composite index is having a forgettable 2025 so far as it recently entered correction territory following remarkable gains in 2023 and 2024 thanks to catalysts such as ...
U.S. stocks plunged, with the tech-heavy Nasdaq and broad S&P 500 posting their biggest one-day drop since September 2022, amid heightened risk of recession this year after President Donald Trump ...
The Nasdaq index is in a correction after falling the last two weeks. American Express is a high-quality credit card issuer that is now trading at a cheap price. The disruption fears with Alphabet ...
In early trading on Tuesday, shares of Intel Corp (INTC) topped the list of the day's best performing components of the Nasdaq 100 index, trading up 9.8%. Year to date, Intel Corp registers a 29.3 ...
Since its peak in December, however, the Nasdaq has dipped into correction territory, falling more than 10% from its recent high. While moves of that magnitude can be unnerving, they also provide ...
The Nasdaq Composite (^IXIC) led the gains, rising almost 2%. The rally at the open marked the first sign of reprieve after the S&P 500 closed on Tuesday down nearly 10% from its most recent all ...
All three major indexes built on losses of more than 2% last week as the Nasdaq plummeted deeper into correction territory. The political uncertainty is expected to persist into this week ...
After all, industry leaders like Nvidia (NASDAQ: NVDA) CEO Jensen Huang project that AI could generate up to $100 trillion in economic value -- a figure that would dwarf the impact of previous ...
Nvidia remains the company best positioned to benefit from increased AI infrastructure spending. Amazon has a history of spending big to win big, and it's spending big on AI. Alphabet has a strong ...
Hyzon expects to file a Form 25 (Notification of Removal from Listing) with the Securities and Exchange Commission (the "SEC") and Nasdaq relating to the delisting of its Common Stock and Warrants ...
Artificial intelligence stocks AppLovin, Palantir, and Nvidia led the Nasdaq-100 higher in 2024, but all three stocks have declined at least 25% from their highs. Pharmaceutical stock Gilead ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results